Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 469 to 478 of 478 entries
Sorted by: Best Match Show Resources per page
Electrospun Nanofibers for Cancer Therapy.

Advances in experimental medicine and biology

Luo H, Jie T, Zheng L, Huang C, Chen G, Cui W.
PMID: 33543460
Adv Exp Med Biol. 2021;1295:163-190. doi: 10.1007/978-3-030-58174-9_8.

Lately, a remarkable progress has been recorded in the field of electrospinning for the preparation of numerous types of nanofiber scaffolds. These scaffolds present some remarkable features including high loading capacity and encapsulation efficiency, superficial area and porosity, potential...

Cite
Luo H, Jie T, Zheng L, et al. Electrospun Nanofibers for Cancer Therapy. Adv Exp Med Biol. 2021;1295:163-190doi: 10.1007/978-3-030-58174-9_8.
Luo, H., Jie, T., Zheng, L., Huang, C., Chen, G., & Cui, W. (2021). Electrospun Nanofibers for Cancer Therapy. Advances in experimental medicine and biology, 1295163-190. https://doi.org/10.1007/978-3-030-58174-9_8
Luo, Huanhuan, et al. "Electrospun Nanofibers for Cancer Therapy." Advances in experimental medicine and biology vol. 1295 (2021): 163-190. doi: https://doi.org/10.1007/978-3-030-58174-9_8
Luo H, Jie T, Zheng L, Huang C, Chen G, Cui W. Electrospun Nanofibers for Cancer Therapy. Adv Exp Med Biol. 2021;1295:163-190. doi: 10.1007/978-3-030-58174-9_8. PMID: 33543460.
Copy Download .nbib Format: NLM
Extracellular vesicles in cancer diagnostics and therapeutics.

Pharmacology & therapeutics

Shehzad A, Islam SU, Shahzad R, Khan S, Lee YS.
PMID: 33465400
Pharmacol Ther. 2021 Jul;223:107806. doi: 10.1016/j.pharmthera.2021.107806. Epub 2021 Jan 17.

Cancer promotion, development, and malignant transformation is greatly influenced by cell-to-cell interactions in a complex tissue microenvironment. Cancer and stromal cells secrete soluble factors, as well as deport membrane-encapsulated structures, which actively contribute and mediate cell-to-cell interaction within a...

Cite
Shehzad A, Islam SU, Shahzad R, et al. Extracellular vesicles in cancer diagnostics and therapeutics. Pharmacol Ther. 2021;223:107806doi: 10.1016/j.pharmthera.2021.107806.
Shehzad, A., Islam, S. U., Shahzad, R., Khan, S., & Lee, Y. S. (2021). Extracellular vesicles in cancer diagnostics and therapeutics. Pharmacology & therapeutics, 223107806. https://doi.org/10.1016/j.pharmthera.2021.107806
Shehzad, Adeeb, et al. "Extracellular vesicles in cancer diagnostics and therapeutics." Pharmacology & therapeutics vol. 223 (2021): 107806. doi: https://doi.org/10.1016/j.pharmthera.2021.107806
Shehzad A, Islam SU, Shahzad R, Khan S, Lee YS. Extracellular vesicles in cancer diagnostics and therapeutics. Pharmacol Ther. 2021 Jul;223:107806. doi: 10.1016/j.pharmthera.2021.107806. Epub 2021 Jan 17. PMID: 33465400.
Copy Download .nbib Format: NLM
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.

Journal of medical Internet research

Trojan A, Leuthold N, Thomssen C, Rody A, Winder T, Jakob A, Egger C, Held U, Jackisch C.
PMID: 34383675
J Med Internet Res. 2021 Aug 05;23(8):e29271. doi: 10.2196/29271.

BACKGROUND: Electronic patient-reported outcomes (ePRO) are a relatively novel form of data and have the potential to improve clinical practice for cancer patients. In this prospective, multicenter, observational clinical trial, efforts were made to demonstrate the reliability of patient-reported...

Cite
Trojan A, Leuthold N, Thomssen C, et al. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. J Med Internet Res. 2021;23(8):e29271doi: 10.2196/29271.
Trojan, A., Leuthold, N., Thomssen, C., Rody, A., Winder, T., Jakob, A., Egger, C., Held, U., & Jackisch, C. (2021). The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. Journal of medical Internet research, 23(8), e29271. https://doi.org/10.2196/29271
Trojan, Andreas, et al. "The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial." Journal of medical Internet research vol. 23,8 (2021): e29271. doi: https://doi.org/10.2196/29271
Trojan A, Leuthold N, Thomssen C, Rody A, Winder T, Jakob A, Egger C, Held U, Jackisch C. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial. J Med Internet Res. 2021 Aug 05;23(8):e29271. doi: 10.2196/29271. PMID: 34383675; PMCID: PMC8380582.
Copy Download .nbib Format: NLM
The Effect of Educational Follow-Up with the Motivational Interview Technique on Self-Efficacy and Drug Adherence in Cancer Patients Using Oral Chemotherapy Treatment: A Randomized Controlled Trial.

Seminars in oncology nursing

Gönderen Çakmak HS, Kapucu S.
PMID: 33766423
Semin Oncol Nurs. 2021 Apr;37(2):151140. doi: 10.1016/j.soncn.2021.151140. Epub 2021 Mar 22.

OBJECTIVES: This study aimed to determine the effect of educational follow-up with the motivational interview technique on drug adherence and self-efficacy in patients with cancer using at least one oral chemotherapy drug.DATA SOURCES: A total of 80 patients with...

Cite
Gönderen Çakmak HS, Kapucu S. The Effect of Educational Follow-Up with the Motivational Interview Technique on Self-Efficacy and Drug Adherence in Cancer Patients Using Oral Chemotherapy Treatment: A Randomized Controlled Trial. Semin Oncol Nurs. 2021;37(2):151140doi: 10.1016/j.soncn.2021.151140.
Gönderen Çakmak, H. S., & Kapucu, S. (2021). The Effect of Educational Follow-Up with the Motivational Interview Technique on Self-Efficacy and Drug Adherence in Cancer Patients Using Oral Chemotherapy Treatment: A Randomized Controlled Trial. Seminars in oncology nursing, 37(2), 151140. https://doi.org/10.1016/j.soncn.2021.151140
Gönderen Çakmak, Huri Seval, and Kapucu, Sevgisun. "The Effect of Educational Follow-Up with the Motivational Interview Technique on Self-Efficacy and Drug Adherence in Cancer Patients Using Oral Chemotherapy Treatment: A Randomized Controlled Trial." Seminars in oncology nursing vol. 37,2 (2021): 151140. doi: https://doi.org/10.1016/j.soncn.2021.151140
Gönderen Çakmak HS, Kapucu S. The Effect of Educational Follow-Up with the Motivational Interview Technique on Self-Efficacy and Drug Adherence in Cancer Patients Using Oral Chemotherapy Treatment: A Randomized Controlled Trial. Semin Oncol Nurs. 2021 Apr;37(2):151140. doi: 10.1016/j.soncn.2021.151140. Epub 2021 Mar 22. PMID: 33766423.
Copy Download .nbib Format: NLM
Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability.

Journal of nanoscience and nanotechnology

Terracciano R, Demarchi D, Ruo Roch M, Aiassa S, Pagana G.
PMID: 33653442
J Nanosci Nanotechnol. 2021 May 01;21(5):2760-2777. doi: 10.1166/jnn.2021.19061.

In recent years the worldwide research community has highlighted innumerable benefits of nanomaterials in cancer detection and therapy. Nevertheless, the development of cancer nanomedicines and other bionanotechnology requires a huge amount of considerations about the interactions of nanomaterials and...

Cite
Terracciano R, Demarchi D, Ruo Roch M, et al. Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability. J Nanosci Nanotechnol. 2021;21(5):2760-2777doi: 10.1166/jnn.2021.19061.
Terracciano, R., Demarchi, D., Ruo Roch, M., Aiassa, S., & Pagana, G. (2021). Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability. Journal of nanoscience and nanotechnology, 21(5), 2760-2777. https://doi.org/10.1166/jnn.2021.19061
Terracciano, Rossana, et al. "Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability." Journal of nanoscience and nanotechnology vol. 21,5 (2021): 2760-2777. doi: https://doi.org/10.1166/jnn.2021.19061
Terracciano R, Demarchi D, Ruo Roch M, Aiassa S, Pagana G. Nanomaterials to Fight Cancer: An Overview on Their Multifunctional Exploitability. J Nanosci Nanotechnol. 2021 May 01;21(5):2760-2777. doi: 10.1166/jnn.2021.19061. PMID: 33653442.
Copy Download .nbib Format: NLM
Building bridges between drug development and cancer science: a tribute to José Baselga's legacy.

Annals of oncology : official journal of the European Society for Medical Oncology

Hyman DM, Soria JC, Tabernero J.
PMID: 33838220
Ann Oncol. 2021 Jul;32(7):825-828. doi: 10.1016/j.annonc.2021.03.209. Epub 2021 Apr 07.

No abstract available.

Cite
Hyman DM, Soria JC, Tabernero J. Building bridges between drug development and cancer science: a tribute to José Baselga's legacy. Ann Oncol. 2021;32(7):825-828doi: 10.1016/j.annonc.2021.03.209.
Hyman, D. M., Soria, J. C., & Tabernero, J. (2021). Building bridges between drug development and cancer science: a tribute to José Baselga's legacy. Annals of oncology : official journal of the European Society for Medical Oncology, 32(7), 825-828. https://doi.org/10.1016/j.annonc.2021.03.209
Hyman, D M, et al. "Building bridges between drug development and cancer science: a tribute to José Baselga's legacy." Annals of oncology : official journal of the European Society for Medical Oncology vol. 32,7 (2021): 825-828. doi: https://doi.org/10.1016/j.annonc.2021.03.209
Hyman DM, Soria JC, Tabernero J. Building bridges between drug development and cancer science: a tribute to José Baselga's legacy. Ann Oncol. 2021 Jul;32(7):825-828. doi: 10.1016/j.annonc.2021.03.209. Epub 2021 Apr 07. PMID: 33838220.
Copy Download .nbib Format: NLM
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop.

BMC health services research

Latimer NR, Pollard D, Towse A, Henshall C, Sansom L, Ward RL, Bruce A, Deakin C.
PMID: 33941174
BMC Health Serv Res. 2021 May 03;21(1):412. doi: 10.1186/s12913-021-06425-0.

BACKGROUND: It is increasingly common for two or more treatments for cancer to be combined as a single regimen. Determining value and appropriate payment for such regimens can be challenging. This study discusses these challenges, and possible solutions.METHODS: Stakeholders...

Cite
Latimer NR, Pollard D, Towse A, et al. Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. BMC Health Serv Res. 2021;21(1):412doi: 10.1186/s12913-021-06425-0.
Latimer, N. R., Pollard, D., Towse, A., Henshall, C., Sansom, L., Ward, R. L., Bruce, A., & Deakin, C. (2021). Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. BMC health services research, 21(1), 412. https://doi.org/10.1186/s12913-021-06425-0
Latimer, Nicholas R, et al. "Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop." BMC health services research vol. 21,1 (2021): 412. doi: https://doi.org/10.1186/s12913-021-06425-0
Latimer NR, Pollard D, Towse A, Henshall C, Sansom L, Ward RL, Bruce A, Deakin C. Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. BMC Health Serv Res. 2021 May 03;21(1):412. doi: 10.1186/s12913-021-06425-0. PMID: 33941174; PMCID: PMC8091555.
Copy Download .nbib Format: NLM
Optimizing Care for Patients With Adverse Events From Immunotherapeutics.

Cancer journal (Sudbury, Mass.)

Sheehan K, Price C, Hafez N.
PMID: 33298725
Cancer J. 2020 Nov/Dec;26(6):537-542. doi: 10.1097/PPO.0000000000000492.

Immune-related adverse events (irAEs) are a common occurrence in patients treated with immune checkpoint inhibitors. Fortunately, the majority of irAEs are mild and easily managed with steroids. As the use of immune checkpoint inhibitors and other immune therapies continues...

Cite
Sheehan K, Price C, Hafez N. Optimizing Care for Patients With Adverse Events From Immunotherapeutics. Cancer J. 2020;26(6):537-542doi: 10.1097/PPO.0000000000000492.
Sheehan, K., Price, C., & Hafez, N. (2020). Optimizing Care for Patients With Adverse Events From Immunotherapeutics. Cancer journal (Sudbury, Mass.), 26(6), 537-542. https://doi.org/10.1097/PPO.0000000000000492
Sheehan, Kelsey, et al. "Optimizing Care for Patients With Adverse Events From Immunotherapeutics." Cancer journal (Sudbury, Mass.) vol. 26,6 (2020): 537-542. doi: https://doi.org/10.1097/PPO.0000000000000492
Sheehan K, Price C, Hafez N. Optimizing Care for Patients With Adverse Events From Immunotherapeutics. Cancer J. 2020 Nov/Dec;26(6):537-542. doi: 10.1097/PPO.0000000000000492. PMID: 33298725.
Copy Download .nbib Format: NLM
Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis.

Integrative cancer therapies

Sun X, Chen Y, Cheung WK, Wu IX, Xiao F, Chung VC.
PMID: 34369188
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211038008. doi: 10.1177/15347354211038008.

OBJECTIVE: Current guidelines have different recommendations on applying pharmacological interventions for managing cancer-related fatigue (CRF) among cancer survivors. This systematic review aims to synthesize clinical evidence on pharmacological interventions for managing CRF.METHODS: Five databases were searched for potential randomized...

Cite
Sun X, Chen Y, Cheung WK, et al. Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis. Integr Cancer Ther. 2021;20:15347354211038008doi: 10.1177/15347354211038008.
Sun, X., Chen, Y., Cheung, W. K., Wu, I. X., Xiao, F., & Chung, V. C. (2021). Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis. Integrative cancer therapies, 2015347354211038008. https://doi.org/10.1177/15347354211038008
Sun, Xuemei, et al. "Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis." Integrative cancer therapies vol. 20 (2021): 15347354211038008. doi: https://doi.org/10.1177/15347354211038008
Sun X, Chen Y, Cheung WK, Wu IX, Xiao F, Chung VC. Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211038008. doi: 10.1177/15347354211038008. PMID: 34369188; PMCID: PMC8358505.
Copy Download .nbib Format: NLM
[Circulating tumour DNA in the treatment of cancer].

Ugeskrift for laeger

Iden CR, Johansen AFB, Øgaard N, Kongsfelt IB, Egebjerg K, Andersen CL, Mau-Sørensen M.
PMID: 34378526
Ugeskr Laeger. 2021 Aug 09;183(32).

Circulating tumour DNA analysis has a potential to improve multiple aspects of cancer management. This includes: a) early cancer detection in asymptomatic individuals, b) identification of patients with residual disease after curative intended treatment, c) patient stratification in relation...

Cite
Iden CR, Johansen AFB, Øgaard N, et al. [Circulating tumour DNA in the treatment of cancer]. Ugeskr Laeger. 2021;183(32)
Iden, C. R., Johansen, A. F. B., Øgaard, N., Kongsfelt, I. B., Egebjerg, K., Andersen, C. L., & Mau-Sørensen, M. (2021). [Circulating tumour DNA in the treatment of cancer]. Ugeskrift for laeger, 183(32), .
Iden, Cecilie Riis, et al. "[Circulating tumour DNA in the treatment of cancer]." Ugeskrift for laeger vol. 183,32 (2021).
Iden CR, Johansen AFB, Øgaard N, Kongsfelt IB, Egebjerg K, Andersen CL, Mau-Sørensen M. [Circulating tumour DNA in the treatment of cancer]. Ugeskr Laeger. 2021 Aug 09;183(32). Danish. PMID: 34378526.
Copy Download .nbib Format: NLM
Showing 469 to 478 of 478 entries